Back to results
US 12,005,138 B2Granted
Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (SPRM), anti-progestin, or anti-progestational agent
AssigneeArkady Rubin
InventorArkady Rubin
Life of this patent
Estimating the term…
Abstract
An intravaginal drug delivery device comprising: a drug delivery device, and a therapeutically effective amount of a single active agent that is therapeutically effective for the treatment of endometriosis, wherein the drug delivery device delivers the single active agent directly to endometrial implants in women diagnosed with endometriosis, wherein the single active agent is selected from the group consisting of mifepristone and metabolites thereof.
Claims6
An intravaginal drug delivery device comprising:
- a drug delivery device;
- and
- a therapeutically effective amount of a single active agent that is therapeutically effective for the treatment of endometriosis, wherein the drug delivery device delivers the single active agent directly to endometrial implants in women diagnosed with endometriosis, wherein the drug delivery device delivers a daily dose of the single active agent which ranges from 10 mcg to 50 mcg, wherein the single active agent is selected from the group consisting of mifepristone and metabolites thereof.
Dependencies are inferred from the claim text.